Business Description
Talis Biomedical Corp
NAICS : 339112
SIC : 3845
ISIN : US87424L2079
Share Class Description:
TLIS: Ordinary SharesDescription
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.9 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -8.87 | |||||
| Beneish M-Score | -5.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 21.1 | |||||
| 3-Year FCF Growth Rate | 25.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.33 | |||||
| 9-Day RSI | 72.08 | |||||
| 14-Day RSI | 65.25 | |||||
| 6-1 Month Momentum % | 92.8 | |||||
| 12-1 Month Momentum % | 20.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.86 | |||||
| Quick Ratio | 8.86 | |||||
| Cash Ratio | 8.75 | |||||
| Days Inventory | 18045.24 | |||||
| Days Sales Outstanding | 181.08 | |||||
| Days Payable | 25222.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.6 | |||||
| Shareholder Yield % | 58.64 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.05 | |||||
| Operating Margin % | -16217.23 | |||||
| Net Margin % | -15050.24 | |||||
| FCF Margin % | -13040.29 | |||||
| ROE % | -64.1 | |||||
| ROA % | -49.42 | |||||
| ROIC % | -237.69 | |||||
| ROC (Joel Greenblatt) % | -329.7 | |||||
| ROCE % | -57.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 40.22 | |||||
| PB Ratio | 0.24 | |||||
| Price-to-Tangible-Book | 0.24 | |||||
| EV-to-EBIT | 0.6 | |||||
| EV-to-EBITDA | 0.61 | |||||
| EV-to-Revenue | -97.81 | |||||
| EV-to-FCF | 0.75 | |||||
| Price-to-Net-Current-Asset-Value | 0.31 | |||||
| Price-to-Net-Cash | 0.32 | |||||
| Earnings Yield (Greenblatt) % | 166.67 | |||||
| FCF Yield % | -327.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talis Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.412 | ||
| EPS (TTM) ($) | -34.18 | ||
| Beta | 1.83 | ||
| Volatility % | 68.19 | ||
| 14-Day RSI | 65.25 | ||
| 14-Day ATR ($) | 0.411642 | ||
| 20-Day SMA ($) | 8.59915 | ||
| 12-1 Month Momentum % | 20.42 | ||
| 52-Week Range ($) | 4.35 - 9.32 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Talis Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Talis Biomedical Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Talis Biomedical Corp Frequently Asked Questions
What is Talis Biomedical Corp(TLIS)'s stock price today?
The current price of TLIS is $9.00. The 52 week high of TLIS is $9.32 and 52 week low is $4.35.
When is next earnings date of Talis Biomedical Corp(TLIS)?
The next earnings date of Talis Biomedical Corp(TLIS) is 2024-05-10 Est..
Does Talis Biomedical Corp(TLIS) pay dividends? If so, how much?
Talis Biomedical Corp(TLIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers